|
Patent: 6,565,803 issued May 20, 2003 and assigned
to Calgon Carbon Corporation:
Title: Method for the inactivation of cryptosporidium
parvum using ultraviolet light
Claims: The patent makes the following verbatim claims:
1. A method for the prevention of infection from cryptosporidium
oocysts found in drinking water comprising irradiating said water
with continuous ultraviolet light having predominant wavelength bands
that falls within about 200 nanometers to about 300 nanometers with
a dose of from about 1 mJ/cm2 to about
175 mJ/cm2.
2. A method as set forth in claim 1 wherein said dose is from about
3.5 mJ/cm2 to about 175 mJ/cm2.
3. A method as set forth in claim 1 or 2 wherein said ultraviolet light
substantially comprises a wavelength of about 254 nanometers.
4. A method as set forth in claim 1 or 2 wherein said ultraviolet light
is produced by one of a low pressure mercury lamp or a medium pressure
mercury lamp.
5. A method as set forth in claim 4 wherein said ultraviolet light
is produced by a low pressure mercury lamp.
6. A method as set forth in claim 4 wherein said ultraviolet light
is produced by a medium pressure mercury lamp.
7. A method for the prevention of replication of cryptosporidium
oocysts or giardia cysts in drinking water treatment comprising
irradiating said water with a continuous source of light having predominant
wavelength bands that falls within about 200 nm to about 300 nm and
a dose of from about 1 mJ/cm2 to about
175 mJ/cm2.
8. A method as set forth in claim 7 wherein said dose is from about
3.5 mJ/cm2 to about 175 mJ/cm2.
9. A method as set forth in claim 7 or 8 wherein said light substantially
comprises a wavelength of about 254 nanometers.
10. A method as set forth in claim 7 or 8 wherein said light is produced
by one of a low pressure lamp or a medium pressure lamp.
11. A method as set forth in claim 10 wherein said light is produced
by a low pressure lamp.
12. A method as set forth in claim 10 wherein said light is produced
by a medium pressure lamp.
13. A method of treating drinking water containing contaminants including
cryptosporidium comprising exposing said water to a continuous
broad band of ultraviolet radiation with a dose of about 1.0 mJ/cm2
to about 175 mJ/cm2, wherein said exposing
step is the sole process for rendering cryptosporidium in said
drinking water noninfectious.
14. A method as set forth in claim 13 wherein said dose is from about
3.5 mJ/cm2 to about 175 mJ/cm2.
Summary of the invention:
”Generally it has been discovered that it is not necessary to
"kill" pathogens, such as Cryptosporidium parvum
or Giardia muris with ultraviolet light in order to prevent
infection; one need only apply enough ultraviolet light to prevent the
organism from "replicating". The method of the present invention
prevents replication (cell mitosis) by inactivating the DNA to prevent
infection. The UV doses required to prevent replication are orders of
magnitude lower than required to "kill" the oocysts. This
means that the cost of UV treatment to prevent infection by Cryptosporidium
oocysts will be markedly lower.
”It has been found that when biological organisms are exposed
to ultraviolet light (UV) in the range of 200-300 nm, the UV can be
absorbed by DNA, RNA, and proteins. Absorption by proteins can lead
to rupture of cell walls and death of the organism. Absorption by DNA
or RNA (specifically by thymine bases) is known to cause inactivation
of the DNA or RNA double helix strands through the formation of thymine
dimers. If enough of these dimers are created in DNA, the DNA replication
process is disrupted and hence, in mitosis, the cell cannot replicate.
Cells that cannot replicate cannot infect. The present invention utilizes
UV doses substantially lower (to achieve the state of hindered replication)
by orders of magnitude than those required to cause oocyst death.
”The present invention preferably utilizes a broad band (200-300
nm) medium-pressure mercury UV lamp to achieve the disinfection. In
another embodiment of the invention, a low-pressure mercury (essentially
monochromatic) UV lamp can be used. The dose required with a medium-pressure
lamp was measured to be 11 mJ/cm2 to
achieve better than 5.9 log disinfection. From this it can be inferred
that a dose of 7 mJ/cm2 will achieve
better than 4 log disinfection (99.99%) and 3.6 mJ/cm2
will achieve better than 2 log disinfection (99%). For low pressure
lamps a dose of 8 and 16 mJ/cm2 was
required to achieve 4.1 and 4.3 log disinfection, respectively. Thus,
the dose levels of UV are significantly lower than those used before
resulting in significantly lower power levels needed to achieve the
results. It has been found that inactivation of Cryptosporidium
and similar organisms such as Giardia occurs at dosages
from about 1 mJ/cm2. Accordingly, the
method provides a substantial improvement in the cost effectiveness
of UV for the disinfection of contaminated drinking water as regards
to Cryptosporidium oocysts and Giardia cysts that
may be present. Other advantages will become apparent from a perusal
of the following detailed description of a presently preferred embodiment
of the invention.”
Patent: 6,129,893 issued October 20, 2000 and assigned
to Calgon Carbon Corporation:
Title: Method for preventing replication in Cryptosporidium
parvum using ultraviolet light
Claims: The patent makes the following verbatim claims:
1. A method for the prevention of cryptosporidium oocysts
comprising irradiating water with a continuous broad band of ultraviolet
light in doses of from about 10 mJ/cm2
to about 175 mJ/cm2.
2. A method as set forth in claim 1 wherein said broad band is a frequency
of 200 to 300 nm using an UV lamp.
3. A method as set forth in claim 1 or 2 wherein said dose is about
20 mJ/cm2 to about 30 mJ/cm2.
4. A method as set forth in claim 1 wherein said broad band is a frequency
of 200 to 300 nm using a medium pressure UV lamp.
Summary of the invention:
“Generally it has been discovered that it is not necessary to
"kill" or "inactivate" pathogens, such as Cryptosporidium
parvum or Giardia muris with ultraviolet light in order
to prevent infection; one need only apply enough ultraviolet light to
prevent the organism from "replicating". The method of the
present invention prevents replication (cell mitosis) by cross-linking
the DNA to prevent infection. The UV doses required to prevent replication
are orders of magnitude lower than required to "kill" or "inactivate"
the oocysts. This means that the cost of UV treatment to prevent infection
by Cryptosporidium oocysts will be markedly lower.
”It has been found that when biological organisms are exposed
to ultraviolet light (UV) in the range of 200-300 nm, the UV can be
absorbed by DNA, RNA and proteins. Absorption by proteins can lead to
rupture of cell walls and death of the organism. Absorption by DNA or
RNA (specifically by thymine bases) is known to cause cross-linking
of the DNA or RNA double helix strands through the formation of thymine
dimers. If enough of these cross links are created in DNA, it cannot
separate into two strands and hence in mitosis, the cell cannot replicate.
Cells that cannot replicate cannot infect. The present invention utilizes
UV doses substantially lower to achieve the state of hindered replication
are much lower (by orders of magnitude) than those required to cause
cell oocyst destruction.
”The present invention utilizes a broadband (200-300 nm) medium
pressure UV lamp to achieve the prevention. Medium pressure UV lamps
provide a continuous ultraviolet spectrum. Medium pressure mercury lamps
contain mercury vapor pressure of about 1000 Hg when they are energized
(low pressure mercury lamps contain mercury vapor pressure of about
0.001 to about 10 mm Hg when they are energized). A. M. Braun, M. T.
Maurette, and E. Oliveros; Photochemical Technology; pp. 109-114; John
Wiley & Sons; 1991. The dose required can be as low as 10 mJ/cm2.
Doses over 30 mJ/cm2 provide more than
4.5 logs removal measured by mouse infectivity. Thus, the dose levels
are significantly lower than used before resulting in significantly
lower power levels needed to achieve the results. Accordingly, the method
provides a substantial increase in the cost effectiveness of UV reduction
in cryptosporidium oocysts infection in drinking water. Other
advantages will become apparent from a perusal of the following detailed
description of a presently preferred embodiment of the invention.”
|